u 99194a has been researched along with tetradecanoylphorbol acetate in 1 studies
| Studies (u 99194a) | Trials (u 99194a) | Recent Studies (post-2010) (u 99194a) | Studies (tetradecanoylphorbol acetate) | Trials (tetradecanoylphorbol acetate) | Recent Studies (post-2010) (tetradecanoylphorbol acetate) |
|---|---|---|---|---|---|
| 62 | 0 | 10 | 31,050 | 61 | 2,217 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ekman, A; Eriksson, E; Hellstrand, M; Nilsson, CL | 1 |
1 other study(ies) available for u 99194a and tetradecanoylphorbol acetate
| Article | Year |
|---|---|
Both dopamine and the putative dopamine D3 receptor antagonist PNU-99194A induce a biphasic inhibition of phorbol ester-stimulated arachidonic acid release from CHO cells transfected with the dopamine D3 receptor.
Topics: Animals; Arachidonic Acid; CHO Cells; Cricetinae; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Indans; Pertussis Toxin; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetradecanoylphorbol Acetate; Transfection; Virulence Factors, Bordetella | 1999 |